Zydus Cadila is set to bolster its portfolio of US complex injectables and improve supply of critical care drugs after signing a license and supply agreement with the Italfarmaco group’s Chemi to launch the Italian firm’s generic version of Lovenox (preservative free enoxaparin sodium) in seven dosage strengths in the US.
Under the terms of the firms’ agreement, Chemi will manufacture and supply the product – for which it owns proprietary rights on a preservative free product formulation in single-use
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?